OnKure Therapeutics, Inc.
OKUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001637715
In the last 90 days, OnKure Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 75 institutions reported holding it in 13F filings for Q2 2026, worth $159.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in OnKure Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −4 vs. Q4 2024
- Shares held
- 11.9M
- +105.9K (+0.9%) vs. Q4 2024
- Total value
- $50.1M
- −$49.1M (−49.5%) vs. Q4 2024
- New holders
- 4
- 15 more added
- Sold out
- 8
- 13 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OKUR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $159.0M |
| Q1 2026 | 51 | $113.9M |
| Q4 2025 | 44 | $32.0M |
| Q3 2025 | 42 | $28.1M |
| Q2 2025 | 49 | $25.8M |
| Q1 2025 | 47 | $50.1M |
| Q4 2024 | 51 | $99.2M |
| Q3 2024 | 51 | $49.0M |
| Q2 2024 | 66 | $41.3M |
| Q1 2024 | 62 | $45.4M |
| Q4 2023 | 68 | $40.4M |
| Q3 2023 | 58 | $208.3M |
| Q2 2023 | 52 | $168.9M |
| Q1 2023 | 35 | $102.0M |
| Q4 2022 | 32 | $38.4M |
| Q3 2022 | 33 | $55.1M |
| Q2 2022 | 33 | $43.3M |
| Q1 2022 | 41 | $50.8M |
| Q4 2021 | 39 | $148.9M |
| Q3 2021 | 38 | $136.7M |
| Q2 2021 | 38 | $170.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding OnKure Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 1,837,739 | $7.90M | 0.60% | 00.0% | Unchanged |
| Acorn Capital Advisors, LLC | 1,439,674 | $5.12M | 3.42% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,068,104 | $4.44M | 0.00% | −6,210−0.6% | Reduced |
| Perceptive Advisors LLC | 1,004,439 | $4.32M | 0.15% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 824,155 | $3.54M | 0.63% | 00.0% | Unchanged |
| Vanguard Group Inc | 706,733 | $3.04M | 0.00% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 635,000 | $2.73M | 0.19% | 00.0% | Unchanged |
| Deep Track Capital, LP | 523,989 | $2.25M | 0.07% | 00.0% | Unchanged |
| StepStone Group LP | 491,938 | $2.12M | 2.17% | 00.0% | Unchanged |
| NEA Management Company, LLC | 478,548 | $2.06M | 0.16% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 438,797 | $1.89M | 0.08% | +39,054+9.8% | Added |
| Tang Capital Management LLC | 400,000 | $1.72M | 0.10% | +105,374+35.8% | Added |
| Affinity Asset Advisors, LLC | 394,159 | $1.69M | 0.27% | +250,000+173.4% | Added |
| Carlyle Group Inc. | 269,895 | $1.16M | 0.03% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 253,754 | $1.09M | 0.36% | 00.0% | Unchanged |
| Prosight Management, LP | 186,570 | $802.3K | 0.26% | +122,816+192.6% | Added |
| Shay Capital LLC | 151,038 | $649.5K | 0.19% | +136,022+905.8% | Added |
| Cantor Fitzgerald, L. P. | 130,700 | $562.0K | 0.02% | +95,000+266.1% | Added |
| BlackRock, Inc. | 88,981 | $382.6K | 0.00% | −5,036−5.4% | Reduced |
| Aisling Capital Management LP | 88,607 | $381.0K | 0.13% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 86,311 | $371.2K | 0.00% | +9,712+12.7% | Added |
| Sphera Funds Management Ltd. | 80,454 | $346.0K | 0.09% | −6,900−7.9% | Reduced |
| Boothbay Fund Management, LLC | 78,021 | $335.5K | 0.01% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 54,208 | $233.1K | 0.02% | −569−1.0% | Reduced |
| Aldebaran Capital, LLC | 45,048 | $193.7K | 0.18% | −524−1.1% | Reduced |
| Renaissance Technologies LLC | 41,863 | $180.0K | 0.00% | −5,587−11.8% | Reduced |
| Two Sigma Advisers, LP | 27,628 | $118.8K | 0.00% | +13,400+94.2% | Added |
| Two Sigma Investments, LP | 27,148 | $116.7K | 0.00% | +27,148 | New |
| Bridgeway Capital Management, LLC | 25,000 | $107.5K | 0.00% | +25,000 | New |
| Northern Trust Corp | 19,177 | $82.5K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 18,663 | $80.3K | 0.00% | +18,663 | New |
| ADAR1 Capital Management, LLC | 10,000 | $43.0K | 0.01% | +10,000 | New |
| Barclays PLC | 6,765 | $29.1K | 0.00% | −1,976−22.6% | Reduced |
| Wells Fargo & Company | 3,620 | $15.6K | 0.00% | +2,000+123.5% | Added |
| China Universal Asset Management Co., Ltd. | 2,538 | $10.9K | 0.00% | −145−5.4% | Reduced |
| Tower Research Capital LLC (TRC) | 2,224 | $9.56K | 0.00% | +23+1.0% | Added |
| Morgan Stanley | 1,878 | $8.08K | 0.00% | +946+101.5% | Added |
| Mirae Asset Global Investments Co., Ltd. | 423 | $1.89K | 0.00% | +1+0.2% | Added |
| GF Fund Management Co. Ltd. | 313 | $1.35K | 0.00% | +47+17.7% | Added |
| BNP Paribas Arbitrage, SA | 297 | $1.28K | 0.00% | +61+25.8% | Added |
| UBS Group AG | 280 | $1.20K | 0.00% | −1,933−87.3% | Reduced |
| JPMorgan Chase & Co | 231 | $993 | 0.00% | −106−31.5% | Reduced |
| Bank of America Corp | 221 | $950 | 0.00% | −249,421−99.9% | Reduced |
| Citigroup Inc | 190 | $818 | 0.00% | +88+86.3% | Added |
| Group One Trading, L.P. | 56 | $241 | 0.00% | −233−80.6% | Reduced |
| MAI Capital Management | 6 | $26 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 32 | $0 | 0.00% | −11−25.6% | Reduced |
| Altium Capital Management LP | 0 | $0 | 0.00% | −218,386−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −144,099−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −43,371−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −20,549−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −18,633−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −13,495−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −12,100−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −152−100.0% | Sold out |